Search results
Pages
-
- Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologists
-
- HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2
-
- Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years
-
- Clinical evidence supporting genomic tests in early breast cancer: Do all genomic tests provide the same information?
-
- Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04)
-
- Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers
-
- Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3
-
- Use of implicit persuasion in decision making about adjuvant cancer treatment: A potential barrier to shared decision making
-
- Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)
-
- Integrating clinicopathological and molecular data in the breast cancer patient : towards precision medicine
-
- The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis
-
- The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis